ArticleThe World Allergy Organization journal2018

Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases.

Zeynep Celebi Sozener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.